Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey.

ABSTRACT:

Background

Anticoagulant treatment of splanchnic (SVT) and cerebral vein thrombosis (CVT) can be challenging due to the rarity of these conditions, the concomitantly high thrombotic and bleeding risks, and the available low-quality evidence.

Objectives

To explore the current therapeutic approaches to SVT and CVT, and the rationale behind the anticoagulant treatment choice.

Methods

A cross-sectional survey was conducted (October 2018-April 2019) among members of three thrombosis and hemostasis societies. The survey consisted of four vignette cases: (i) SVT secondary to transient risk factor; (ii) cirrhotic SVT with esophageal varices; (iii) CVT secondary to transient risk factor; and (iv) unprovoked CVT with intracranial hemorrhage.

Results

A total of 397 physic

SUBMITTER: Riva N 

PROVIDER: S-EPMC7590282 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature